Dividend Stocks

When recessions strike, the share prices of just about every company fall. This is because stocks are forward-looking and tend to overreact to both the upside and the downside. And when recessions do strike, investors rapidly discount negative earnings growth in the form of lower share prices. For some stocks, however — like Walmart (NYSE:WMT)

In today’s near-zero interest rate environment, it’s been tough for investors looking for yield. There are many high-yielding dividend stocks to buy, but with markets at all-time highs, many of them have gotten stretched when it comes to valuation. With concerns 2020’s overvalued stock market will head lower in 2021, it may not be best

Due to a combination of several factors, Pfizer’s (NYSE:PFE) vaccine for the novel coronavirus, by itself, may not ever move the needle a great deal for PFE stock. Source: Manuel Esteban / Shutterstock.com On the other hand, over the long-term, Pfizer’s collaboration with German vaccine developer BioNTech (NASDAQ:BNTX), which developed the mRNA-based coronavirus vaccine with

After surging on vaccine news, Pfizer (NYSE:PFE) stock has slid back since early December. To me, this recent pullback in Pfizer stock is a bit of surprise. Source: Manuel Esteban / Shutterstock.com Why? Sure, economic upside from BNT162b2, which it developed with BioNTech (NASDAQ:BNTX), may moderate relative to the pharma giant’s size. For a smaller

Pfizer (NYSE:PFE) is in the news lately for the rollout of its Covid-19 vaccine. However, much of the earnings from vaccines is already taken into account by the market in the Pfizer stock price already. Source: Manuel Esteban / Shutterstock.com Nevertheless, Pfizer is worth at least 20% more based on its dividend yield history as

Exxon Mobil (NYSE:XOM) and Chevron (NYSE:CVX) – in oil, these are the two big guns, always compared with one another. In 2020, CVX stock has done “better,” but it’s been something of a booby prize. Shares are down almost 26%, which is terrible except Exxon is down nearly 40%. Source: Jeff Whyte / Shutterstock.com Next

This pandemic has accelerated change in markets everywhere. And maybe nowhere is this truer than in the energy sector. For instance, Exxon Mobil (NYSE:XOM) has defined energy for decades, becoming one of the world’s most powerful companies. Now, though, XOM stock is faltering and oil isn’t the only energy option. In fact, demand for Exxon’s

Tobacco stocks have long been a favorite among income investors. Why? For one, they often pay high dividend yields above 5%. A select few have also maintained long histories of raising their dividends, even during recessions. On top of that, the industry enjoys multiple advantages that make it attractive for investment. The best names in

At the beginning of October, I wrote that BP (NYSE:BP) was worth about $21 or so, based on its historical yield and the company’s cash flow. Now, however, BP stock has touched $22 in the past two months. I believe the stock will stay close to these levels unless something changes. Source: Shutterstock For example,

At Sure Dividend, we recommend investors focus their portfolios on high-quality dividend stocks. More specifically, this refers to companies with leadership positions in their industry, that possess durable competitive advantages. These companies also have the ability to pay dividends to shareholders. The best dividend stocks can generate excellent long-term returns. Even better, investors can buy

Since its last earnings report, Exxon Mobil (NYSE:XOM) stock is up 32%. That is great news for those long the stock, but the easy money in this bounce is ending. This is the point of today’s cautionary tale. My goal is not to discount the future prospects of such a successful company. I am merely saying

Exxon Mobil (NYSE:XOM) has made it more than clear it will do it what it takes to maintain its beefy dividend. That makes XOM stock a great bargain even after rising over 20% in the past month to $41.68 at the Dec. 7 market close. Source: Jonathan Weiss / Shutterstock.com Moreover, the stock has a

As trading opens this morning, shares in JPMorgan Chase (NYSE:JPM) still cost 11% less than at the start of the year. At $122 each, that’s a market capitalization of about $370 billion. JPM stock has a modest price-to-earnings ratio of 15.7, and the 90 cents per share dividend still yields nearly 3%. Source: Bjorn Bakstad

The Federal Reserve slashed interest rates back in March in protecting the economy from the crippling economic effects of Covid-19. Dividend stocks became doubly important for investors, with savings yields taking a battering. Thankfully, the pandemic-induced economic recession hasn’t affected dividend stocks as viciously as in the 2008 financial crisis did. For example, dividend payouts

The real estate sector is one of the duds in the S&P 500. This is highlighted by a year-to-date decline of almost 9% for the widely followed MSCI US Investable Market Real Estate 25/50 Index, confirming the struggle is real for real estate investment trusts (REITs). Making the performance of the broader REIT universe all

Income investors are typically focused on dividends first and foremost. There is good reason for this — high-quality dividend growth stocks like the Dividend Aristocrats have often produced superior long-term returns with lower volatility than the S&P 500. Top dividend stocks have the ability to provide income to shareholders year after year, even during recessions.

It’s good to go out on top, and Ed Stack should know. Stack announced he will retire as CEO of Dick’s Sporting Goods (NYSE:DKS) in February, after 36 years at the helm. His father was the eponymous Dick. But when Ed joined the “chain” it had just two stores. Now it has 850 and DKS stock

2020 has been a year like no other. Source: iQoncept/shutterstock.com Tragic wildfires in Australia and California. Social justice protests and riots across the U.S. A contested presidential election. A pandemic that shuttered schools and businesses around the world during the spring, as well as reignited restrictions with the fall resurgence of the virus. A subsequent

Johnson & Johnson (NYSE:JNJ) is one of America’s most well-known brands, and it also has the largest market capitalization of any healthcare company in the U.S. But is JNJ stock a buy today? Source: Alexander Tolstykh / Shutterstock.com In fact, the 134-year-old company still has quite a bit going for it. It is broadly diversified,

If this month’s earth-shattering vaccine news from Pfizer (NYSE:PFE) has you thinking about buying the stock because it’s destined for monster gains – think again. PFE stock is not a growth play. Source: Manuel Esteban / Shutterstock.com It’s a cash-flow vehicle. But don’t take my word for it. Let the market be your guide. The